Association of Sepsis with Iron Overload in Hemodialysis Patients Receiving Intravenous Iron Therapy

Devaki, Ramakrishna and Rao, Pragna (2011) Association of Sepsis with Iron Overload in Hemodialysis Patients Receiving Intravenous Iron Therapy. Asian Journal of Biochemistry, 6 (3). pp. 252-262.

[img] PDF
252-262.pdf - Published Version
Restricted to Registered users only

Download (676kB) | Request a copy

Abstract

Intravenous (IV) iron used to treat anemia of Chronic Kidney Disease (CKD) in Hemodialyzed (HD) patients, may lead to iron overload. The incidence of sepsis in CKD patients with iron overload was studied. Procalcitonin and pro-inflammatory cytokines were used as markers. Serum procalcitonin was estimated semi quantitatively and pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) were quantified by ELISA. The study groups comprised of CKD patients on hemodialysis, receiving IV iron (n = 33) and CKD patients not on hemodialysis and receiving oral iron therapy (n = 36). Among patients receiving IV iron and on HD, non-survivors had significant (p<0.05) iron overload. 36.7% of HD patients had hyperferritinemia (>800 ng mL-1. Among them, those having PCT>10 ng mL-1, had a mortality of 67%. Elevated interleukin-6 and tumor necrosis factor-α were associated with higher rates of mortality. Iron overload is an additional risk factor propagating sepsis in hemodialyzed patients

Item Type: Article
Uncontrolled Keywords: Chronic Kidney Disease; Hyperferritinemia; Hemodialysis; Interleukin-6; Sepsis; Procalcitonin; Tumor necrosis factor a; SIRS
Subjects: Medicine > KMC Manipal > Biochemistry
Depositing User: KMC Manipal
Date Deposited: 17 May 2014 04:12
Last Modified: 17 May 2014 04:12
URI: http://eprints.manipal.edu/id/eprint/139534

Actions (login required)

View Item View Item